Abstract Proinflammatory cytokines and secretory phospholipase A 2 (sPLA 2 ) are elevated in patients with inflammatory bowel disease (IBD). We previously reported that the proinflammatory cytokine IL-6 increased the expression of sPLA 2 (a hydrolyzer of phosphatidylcholine) and decreased membrane integrity in an intestinal epithelial cell culture model. To determine the physiological effects of the IL-6 mediated increase in sPLA 2 on decreased epithelial layer integrity, we investigated alterations of intracellular/secretory phospholipid (PL) composition in a cell culture model. In addition, since other PLs may also mediate epithelial membrane activity, we investigated the effect of IL-6 on PL activity in a Caco-2 enterocyte culture model. Caco-2 cells were incubated for 72 h with IL-6 or media alone (control). Both media and cell lysate were analyzed for PL composition using thin-layer chromatography. The PL composition in the media did not show any differences between the two groups (p>0.1). Total intracellular PL contents were also unchanged; however, IL-6 led to significant changes in PL composition including an increase in phosphatidylethanolamine (PE) and sphingomyelin (SM) and a decrease in phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) (p<0.05). Both PE and SM are known as inflammatory signaling factors involved in human IBD. Our study suggests that the decreased membrane integrity seen with IL-6 application may occur via intracellular PL alterations, rather than through the direct effects of sPLA 2 .
Introduction
Elevated proinflammatory cytokine levels are present in patients with inflammatory bowel disease (IBD) [1, 2, 3] . In particular, the stimulated inflammatory cytokine interleukin-6 (IL-6) seems to play an important role in maintenance of immune suppression in septic patients [4, 5] . In a human intestinal epithelial cell culture model, IL-6 has been shown to mediate a selective down-regulation of enterocyte membrane hydrolase, which normally protects the intestinal barrier function [6, 7] . Another mediator elevated in septic shock is secretory phospholipase A 2 (sPLA 2 ), which is a major enzyme produced in response to proinflammatory cytokines and is found in inflammatory fluids as well as in the serum of patients suffering from septic shock [8, 9] .
The presence of sPLA 2 may have significant physiological influence. It has been reported that the PLA 2 hydrolysis product of phosphatidylcholine (PC), lysophosphatidylcholine (L-PC), causes a loss of epithelial barrier integrity in both rat models [10, 11] and an enterocyte cell culture model [12] . We have previously shown that the proinflammatory cytokine IL-6 increases sPLA 2 concentrations and decreases cellular membrane integrity in an intestinal epithelial cell culture model (presented at the 14th International Symposium on Pediatric Surgical Research, 2001, Madrid); however, the specific physiological effect of increased sPLA 2 secretion in this model is unknown. To determine the physiological effects of the IL-6 mediated increase in sPLA 2 on decreased epithelial layer integrity, we investigated alterations of intracellular/secretory phospholipid (PL) composition in this cell culture model.
Materials and methods

Cell culture
Human enterocyte Caco-2 cell line (no. HTB37) were obtained from the American Type Culture Collection (Manassas, Va.). Caco-2 cell line passages 26-35 were grown in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (Fisher, Pittsburgh, Pa.), 1% non-essential amino acids (Gibco, Grand Island, NY), 1% sodium pyruvate (Fisher, Pittsburgh, Pa.), penicillin G (100 U/ml), and streptomycin (100 g/ml; Fisher, Pittsburgh, Pa.), in a 5% CO 2 atmosphere at 37°C. After reaching 60-70% confluence, cells were harvested by trypsinization with trypsin-EDTA (Gibco, Grand Island, N.Y.), washed and resuspended in DMEM. Caco-2 cells were seeded onto two types of cell culture plates at a density of 1·10 5 cells per well; one was a 3-cm diameter cell culture dish and the other Transwell cell culture inserts with 0.33-cm 2 -sized porous filters (pore size 0.3 lm), coated with 1.0 mg/ml rat-tail type-I collagen (Sigma, St. Louis, Mo.) in a two-chamber cell culture system (Costar, Cambridge, Mass.). Caco-2 cells were then grown for 14 days in media to allow them to reach confluence and fully differentiate. Media were changed every second day. Cell monolayers were used after a TEER of over 200 ohm/cm 2 was measured in the 0.33-cm 2 -sized filters.
Experimental models
Well-differentiated Caco-2 cell monolayers in Transwell cell culture systems were used for investigating the effect of cytokine IL-6 (US Biological, www.usbio.net) on epithelial integrity by measuring transepithelial electrical resistance (TEER) and mannitol paracellular permeability. The cell monolayers were then incubated with media or media with the cytokine IL-6 (10 ng/ml) in the basal chamber for 72 h. Transepithelial electrical resistance (TEER) was measured before and 72 h after cytokine treatment using an epithelial volt ohmmeter (EVOM; World Precision Instruments, Sarasota, Fla.). The TEER values obtained in the absence of cells were used as background, and resistance was expressed as ohm · square centimeters (ohm cm 2 ). Media samples from the apical and basal chambers were then collected for total sPLA 2 activity and phospholipid concentration.
3 H-Mannitol was used as another measure of cellular monolayer integrity. After 72 h incubation with media, or media with IL-6, the monolayers were washed with media and then 3 H-mannitol (molecular formula weight 182.2) was administrated into the apical chamber for investigating permeability. After 2 h incubation with 3 H-mannitol at room temperature or at 4°C, the media in the basal chamber was collected and measured for the presence of 3 Hmannitol. The data are expressed as percent ratio of tritium in the basal chamber / (tritium in basal chamber + the tritium in apical chamber) · 100. Another measuring tool to assess paracellular permeability, Dextran Blue (DB; molecular weight 2,000,000) was also used. After 72 h of incubation with media or media with IL-6, the monolayers were washed by media and then DB was administered into the apical chamber. After 2 h of incubation with DB, the media in the basal chamber was collected and measured using a spectrophotometer at 620 nm. The DB concentrations were determined following comparisons with a standard curve of DB.
Human synovial SPLA 2 secreted into the media was measured by Enzyme Immunoassay (ELISA) kit (Cayman Chemical, Ann Arbor, Mich.). Media samples were collected, centrifuged, and the supernatants were stored at )80°C. All samples were analyzed according to the manufacturer's instructions. Briefly, 100 ll of diluted samples were applied in duplicate to each well of a 96 well plate coated with a monoclonal antibody specific for sPLA 2 . Next, 100 ll of acetylcholinesterase: Fab' Conjugate (AchE: Fab'), which binds selectively to a different epitope on the sPLA 2 molecule, was added to the wells and incubated overnight at 4°C. All solutions from the wells were removed, and the wells were rinsed six times with a wash buffer, followed by the addition of 200 ll of Ellmen's Reagent and allowed to incubate 3 h in the dark at room temperature. The absorbance was read at 420 nm using model 550 Microplate Reader (Bio-Rad, Hercules, Calif.) and the results were compared with a standard curve of sPLA 2 .
Phospholipid composition of the media and cell lysates was measured after 72 h of incubation with media or media with IL-6. Four-milliliter media samples were collected and immediately frozen and stored at )70°C until assayed. The cell monolayers were harvested by trypsinization with trypsin-EDTA and the cell lysate was immediately frozen and stored at )70°C until assayed. Total lipids were extracted using a chloroform/methanol method [13] . Lipid extracts were dried under nitrogen gas, dissolved in chloroform and the total phospholipid content determined as phospholipid phosphorus [14, 15] . Extracted total phospholipids were separated by thin-layer chromatography (TLC) on silica gel 60 plates using chloroform/methanol/acetic acid/water (60:18:21:1.8). Plates with individual phospholipids were placed in 8% (wt./vol.) CuSO 4 phentahydrate in water/methanol/concentration H 3 PO 4 (60:32:8) or 0.1% (wt./vol.). Ninhydrin in ethanol was used for visualization after autoclaving (150°C, 15 min, 110°C, 10 min, respectively). The TLC plates were scanned and the individual PL's band images were then quantified using an imaging computer program Kodak EDAS 290 system (Kodak, Rochester, N.Y.). Individual phospholipid concentrations were compared with the following phospholipids; egg-yolk PC or lysophospholipid; LPC (Sigma) which functioned as standards. The percent of phosphatidylcholine from the chromatographic analysis was used to calculate the total PC content in the lipid extract. The results are reported as phosphatidylcholine phosphorus/milliliters of media and phosphatidylcholine phosphorus/ total amount of phosphate (mol.) of cells obtained from the epithelial monolayer.
Statistical analysis
Results are expressed as mean±SD. Statistical analysis was performed using linear regression analysis and one-way analysis of variance, with P<0.05 considered significant.
Results
The cytokine IL-6 caused a significant decrease in TEER (135±29 ohm cm 2 ) compared with controls (337±0.1 ohm cm 2 ; P<0.05; Fig. 1 ). IL-6 also caused a significant increase in Ma-Pm at both room temperature and at 4°C (1.23±0.27 and 0.50±0.06%, respectively) compared with controls (0.42±0.04 and 0.14±0.03%, respectively; P<0.05; Fig. 2) ; however, DB permeability following IL-6 administration did not change compared with controls.
Secretion of sPLA 2 is shown in Fig. 3 . IL-6 led to a significant increase in total sPLA 2 secretion (143.8±12 ng sPLA 2 /mg DNA) compared with controls (34.4±2.8 ng sPLA 2 /mg DNA; P<0.05).
There were no differences in total media PL composition between the two groups (p>0.1). Total intracellular PL contents were also unchanged; however, percent ratios of specific PLs were altered after IL-6 treatment (Fig. 4) . IL-6 led to significant changes in PL composition, including an increase in PE (9.6%) and SM (5.7%) and a decrease in PC (8.7%) and LPC (40.7%; P<0.05) compared with controls.
Discussion
Cytokines, specifically IL-6, have been shown to be increased in patients with IBD [1, 2, 3, 16] . Moreover, IBD patients are more prone to develop bacterial translocation (BT), which may be related to increased intestinal epithelial permeability. Phospholipases have been recognized as a major enzyme group which have a critical role in diverse cellular responses, including phospholipid digestion and metabolism, host defense and signal transduction [17] . Secretory PLA 2 and cytosolic PLA 2 (cPLA 2 ) have different functions; sPLA 2 appears to be a key factor in the inflammatory process [17] , whereas cPLA 2 functions mainly as a cell signaling factor [18] .
Increased sPLA 2 is found in inflammatory fluids as well as in the serum of patients with rheumatoid arthritis [19] , septic shock [8, 9] , and IBD [20, 21, 22] . The expression of sPLA 2 is increased in a variety of mammalian tissues, and is also increased in cancer patients [23] . The sPLA 2 is understood to be correlated with cell growth, as demonstrated in an in vitro model of epithelial injury, in which sPLA 2 , in a dose-dependent manner, stimulated rat intestinal epithelial cells (IEC-6) to migrate [24] . Other studies in murine intestinal cells have shown that sPLA 2 inhibitors prevented the growth of malignant cells [25] . In our preliminary study, sPLA 2 secretion showed a linear rise (r=0.89) with increasing cell numbers, which suggests that sPLA 2 Cytokine administration shows a close correlation with sPLA 2 secretion and leads to a reduction in TEER. Recombinant human IL-6 can increase serum concentrations of sPLA 2 in humans [26] . Crowl et al. showed that IL-6 led to an up-regulation of sPLA 2 gene expression in human hepatoma cells [27] .
We hypothesized at the initiation of this study that high levels of the cytokine IL-6, as seen in IBD, would stimulate the secretion of sPLA 2 , resulting in epithelial barrier function breakdown through the increased LPC produced by sPLA 2 . In our study, we showed that IL-6 led to both a decline in TEER and an increase in Ma-Pm, suggesting that epithelial barrier function is decreased. In addition, we showed increased sPLA 2 secretion in the IL-6 treated epithelial cell culture model. Based on these findings, we hypothesized that the increased sPLA 2 would correlate with increased LPC products or alteration of secreted PLs in the media; however, the levels of PLs secreted into the between pre-and post-treatment with media (control group) or media with IL-6 (IL-6 group). Asterisk Significant difference between controls and IL-6 treatment group, P<0.05. Open columns control group, solid column IL-6 group media were unchanged compared with controls. It is possible that secreted sPLA 2 as induced by IL-6 might have another action which induces the loss of epithelial membrane integrity. One such possibility is an alteration in the formation of intracellular lipid content, as it has been shown that sPLA 2 can promote cholesterol absorption [28] .
On the other hand, it was interesting to note that intracellular PLs were significantly altered following IL-6 treatment in this model. These changes consisted of increased PE and SM and a decrease in PC and LPC. The PE and SM have been identified as signaling molecules in cellular apoptosis [29, 30, 31] . In our model, apoptotic changes were not evident at 72 h following Il-6 treatment (data not shown).
An increase in IL-6 caused by an inflammatory process in the intestine might have the following physiological effects: one is increased permeability caused by decreased epithelial cell membrane resistance and increased uptake of antigens through paracellular routes or by active transport. Secondly, increased IL-6 production may stimulate increased sPLA 2 secretion into the intestinal lumen, which then leads to secondary epithelial membrane breakdown. Thirdly, increased IL-6 secretion may increase the intracellular PL's PE and SM which function as signaling compounds for either inflammation or apoptosis.
Conclusion
In conclusion, this study demonstrates that IL-6 mediates sPLA 2 secretion and causes a decrease in epithelial integrity as measured by TEER and Ma-PM; however, the increased sPLA 2 produced by IL-6 treatment does not lead to increased LPC concentrations. On the other hand, IL-6 secretion leads to significant alterations in phospholipid content including intracellular phosphatidylethanolamine and sphingomyelin. It is possible that there may be a relationship between the increased sPLA 2 produced by IL-6 treatment and alteration in intracellular PL composition. Further investigation is needed, however, to better understand this mechanism. These facts might help us to understand the mechanisms involved in the loss of epithelial permeability in IBD patients and its relationship to increased cytokine production, especially IL-6. Fig. 4 Phospholipid (PL) alteration after IL-6 treatment measured by thin-layer chromatography. Asterisk Significant difference between controls and IL-6 treatment group, P<0.05. PC phosphatidylcholine, PG phosphatidylglycerol, PE phosphatidylethanolamine, SM sphingomyelin, LPC lysophosphatidylcholine. Open columns control group, solid columns IL-6 group
